Title: LegoChem and Green Cross signed an agreement for development of anticoagulant
Publication: Etoday / Sang Heui Cho
Date: 8 June 2009
Summary
To view the full article (in Korean), click here ▶
About
LegoChem Biosciences
LegoChem
Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to
discovering, developing, and commercializing innovative medicines by leveraging
our chemistry expertise to make conventional biologics targeted and more potent
for the benefit of patients with diseases of high unmet medical needs. We are
advancing sustainable pipelines in therapeutic areas in antibiotics,
anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug
conjugate (PDC).
|
|
IP : 106.243.208.*** 
|
